Leptin as local inflammatory marker in COPD

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Leptin as local inflammatory marker in COPD.

Broekhuizen R, Vernooy JH, Schols AM, Dentener MA, Wouters EF.

Department of Respiratory Medicine, Nutrition and Toxicology Research Institute Maastricht, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. r.broekhuizen@pul.unimaas.nl

INTRODUCTION: Chronic inflammation of the lung is a characteristic finding in chronic obstructive pulmonary disease (COPD). Leptin is a pleiotropic cytokine thought to play a role in host response to inflammation. As recent studies have shown that leptin receptors are present in the lung, this study aimed to determine if leptin is detectable in induced sputum of COPD patients and if there is a relationship between leptin and other inflammatory markers in sputum. METHODS: Sputum was induced in 14 male patients with moderate COPD (FEV1: 56 (15) % pred.). Leptin, total tumour necrosis factor (TNF)-alpha, and C-reactive protein (CRP) were analyzed in induced sputum supernatant by ELISA. Leptin was also determined in EDTA plasma. RESULTS: Leptin was detectable in induced sputum of 10 COPD patients. A significant relationship was found between sputum leptin and CRP (r = 0.943, P < 0.001) and total TNF-alpha (r = 0.690, P < 0.01). Plasma leptin and sputum leptin were inversely correlated (r = -0.643, P < 0.01). CONCLUSION: The present study demonstrated that leptin is detectable in induced sputum of patients with moderate COPD and is related to other inflammatory markers. The observed correlations between leptin and inflammatory markers in sputum may indicate that leptin is involved in the local inflammatory response in COPD
Original languageEnglish
Pages (from-to)70-74
JournalRespiratory Medicine
Volume99
Issue number1
DOIs
Publication statusPublished - 1 Jan 2005

Cite this